B of A Securities Downgrades Amrize to Underperform, Lowers Price Target to $40

Benzinga Newsdesk www.benzinga.com Negative 88.6%

Neg 88.6% Neu 0% Pos 0%

B of A Securities analyst Arnaud Lehmann downgrades Amrize (NYSE:AMRZ) from Neutral to Underperform and lowers the price target from $50 to $40.